Cargando…

Postoperative Bleeding After Administration of a Single Dose of Rivaroxaban to a Patient Receiving Antiretroviral Therapy

A 62-year-old man was admitted to hospital for elective revision of a left total hip arthroplasty. His history was significant for human immunodeficiency virus (HIV) infection for which he was taking the following antiretroviral agents (ARVs): etravirine, ritonavir, darunavir, raltegravir and tenofo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corallo, Carmela E., Grannell, Louise, Tran, Huyen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005638/ https://www.ncbi.nlm.nih.gov/pubmed/27747723 http://dx.doi.org/10.1007/s40800-015-0014-4

Ejemplares similares

Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban, Enoxaparin, or Aspirin for Thromboprophylaxis
por: Lindquist, Desirae E., et al.
Publicado: (2018)

Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy
por: Wells, Philip S, et al.
Publicado: (2014)

Bleeding After a Single Dose of Ketorolac in a Postoperative Patient
por: Gupta, Anupam K, et al.
Publicado: (2020)

Comparison of co-administration of amiodarone and rivaroxaban to co-administration of dronedarone and rivaroxaban for hemorrhage risks after atrial fibrillation ablation
por: Zhang, Peng, et al.
Publicado: (2022)

Effect of Co-Administration of Rivaroxaban and Clopidogrel on Bleeding Time, Pharmacodynamics and Pharmacokinetics: A Phase I Study
por: Kubitza, Dagmar, et al.
Publicado: (2012)

Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin
por: Coleman, Craig I., et al.
Publicado: (2021)

A stain on iron therapy
por: Canning, Martin, et al.
Publicado: (2020)

Postoperative bleeding after percutaneous transhepatic gallbladder drainage and aspiration in patients receiving antithrombotic therapy
por: Iwamoto, Takayuki, et al.
Publicado: (2023)

Reduced- or Half-Dose Rivaroxaban Following Left Atrial Appendage Closure: A Feasible Antithrombotic Therapy in Patients at High Risk of Bleeding?
por: Zhou, Xiao-Dong, et al.
Publicado: (2023)

Risk of Gastrointestinal Bleeding with Rivaroxaban: A Comparative Study with Warfarin
por: Sherid, Muhammed, et al.
Publicado: (2016)

Analysis of Effectiveness, Safety, and Bleeding Related to Rivaroxaban in Elderly Patients
por: Hou, Huimin, et al.
Publicado: (2020)

Intravenous Thrombolysis in a Stroke Patient Receiving Rivaroxaban
por: Fluri, Felix, et al.
Publicado: (2013)

Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin
por: Boonyawat, Kochawan, et al.
Publicado: (2021)

Rivaroxaban administration after acute ischemic stroke: The RELAXED study
por: Yasaka, Masahiro, et al.
Publicado: (2019)

Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban
por: Kirchhof, Paulus, et al.
Publicado: (2020)

Bleeding Complication of Triple Therapy of Rivaroxaban, Prasugrel, and Aspirin: A Case Report and General Discussion
por: Gruenebaum, Dane D., et al.
Publicado: (2014)

Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban
por: Charlton, Blake, et al.
Publicado: (2018)

Rivaroxaban: Bleeding from fungating breast cancer wound: case report
Publicado: (2021)

When should I take my medicines?
por: Grannell, Louise
Publicado: (2019)

Drug interaction resources: mind the gaps
por: Grannell, Louise
Publicado: (2020)

Tardive Dyskinesia in a Postoperative Gynecological Patient After Single Dose Administration of Metoclopramide
por: Wong, Christina S, et al.
Publicado: (2021)

Initial rivaroxaban dosing in patients with atrial fibrillation
por: Ablefoni, Kaja, et al.
Publicado: (2019)

Breast abnormalities in adolescents receiving antiretroviral therapy
por: Dunlop, Jackie L., et al.
Publicado: (2019)

Rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report
por: Börekci, Elif
Publicado: (2019)

Factors That Determine the Prothrombin Time in Patients With Atrial Fibrillation Receiving Rivaroxaban
por: Huang, Jen-Hung, et al.
Publicado: (2018)

Biological Variation in Rotational Thromboelastometry in Patients with Atrial Fibrillation Receiving Rivaroxaban
por: Božič Mijovski, Mojca, et al.
Publicado: (2022)

Effect of Local Fibrinogen Administration on Postoperative Bleeding in Open Prostatectomy Surgery
por: Janatmakan, Farahzad, et al.
Publicado: (2018)

Spinal epidural haematoma following rivaroxaban administration after total knee replacement
por: Madhisetti, Koteshwara Rao, et al.
Publicado: (2015)

Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban‐treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding
por: Kline, Jeffrey A., et al.
Publicado: (2016)

Low-dose rivaroxaban: can cardiovascular events be reduced?
por: De Luca, Leonardo
Publicado: (2023)

Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
por: Abraham, Neena S, et al.
Publicado: (2015)

Bleeding and Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation Treated with Apixaban or Rivaroxaban
por: ABDULLAH, Ahmad Salihin, et al.
Publicado: (2022)

Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism
por: Bistervels, Ingrid M., et al.
Publicado: (2022)

Risk Factors for Rivaroxaban-Related Bleeding Events—Possible Role of Pharmacogenetics: Case Series
por: Šimičević, Livija, et al.
Publicado: (2023)

ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban
por: Kim, Hamin, et al.
Publicado: (2023)

Single and Repeated Doses of EGb 761(®) do not Affect Pharmacokinetics or Pharmacodynamics of Rivaroxaban in Healthy Subjects
por: Hoerr, Robert, et al.
Publicado: (2022)

Treatment outcomes in patients receiving combination antiretroviral therapy
por: Agu, Kenneth, et al.
Publicado: (2010)

Tranexamic acid therapy for postoperative bleeding after bariatric surgery
por: Klaassen, R. A., et al.
Publicado: (2018)

Decreased Rivaroxaban Levels in a Patient with Cerebral Vein Thrombosis Receiving Phenytoin
por: Becerra, Ana F., et al.
Publicado: (2017)

Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban
por: Liu, Xiao-Qin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a7alt1nj7p85n0vt3o0rdbtbvu